Uterine sarcoma Part I—Uterine leiomyosarcoma: The Topic Advisory Group systematic review
Uterine sarcomas account for 3–7% of all uterine cancers. Because of their rarity, unknown etiology, and highly divergent genetic aberration, there is a lack of consensus on risk factors for occurrence and predictive poor outcomes as well as optimal therapeutic choices. Tumor types according to the...
Similar Items
-
Tellimagrandin II, A Type of Plant Polyphenol Extracted from <i>Trapa bispinosa</i> Inhibits Antibiotic Resistance of Drug-Resistant <i>Staphylococcus aureus</i>
by: Yu-Wei Chang, et al.
Published: (2019-11-01) -
Insulin Reduces Inflammation by Regulating the Activation of the NLRP3 Inflammasome
by: Yu-Wei Chang, et al.
Published: (2021-02-01) -
Prognostic Factors for Advanced Pancreatic Cancer Treated with Gemcitabine Plus S-1: Retrospective Analysis and Development of a Prognostic Model
by: Ching-Fu Chang, et al.
Published: (2019-01-01) -
Human Papillomavirus Deoxyribonucleic Acid Sequences and Clinical Outcomes of Cervical Cancer Patients Following Radiotherapy
by: Ching-Cheng Tseng, et al.
Published: (2004-03-01) -
Lipopolysaccharide-Induced Nitric Oxide, Prostaglandin E2, and Cytokine Production of Mouse and Human Macrophages Are Suppressed by Pheophytin-b
by: Chun-Yu Lin, et al.
Published: (2017-12-01)